Back

Applicability of the AHA/ACC/HRS guideline for implantable cardioverter defibrillator implantation in Japanese patients with cardiac sarcoidosis

27 August 2021 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Device therapy e-posters Implantable Cardioverter-Defibrillator (ICD) ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Doctor Sakae Takenaka

Hokkaido University, Sapporo (Japan)

42 More presentations in this session

Presentation thumbnail
Intraoperative echocardiography for electrode implantation into the left bundle branch region in patients with indications for cardiac resynchronization therapy
Doctor N. Pavlinova (Odessa, UA)
Abstract Slides
Presentation thumbnail
Adherence to guidelines of diagnostic and therapeutic practices for suspected infections of cardiac implantable electronic devices
Doctor G. De Ciancio (NANCY, FR)
Abstract Slides
Presentation thumbnail
Prognostic effect of the electrocardiographic pattern following cardiac resincronization
Mr J. Asensio Nogueira (Burgos, ES)
Abstract Slides
Presentation thumbnail
Single- vs dual-chamber ICDs to prevent from inappropriate shocks: the debate is still alive
Doctor S. Briongos Figuero (Madrid, ES)
Abstract Slides
Presentation thumbnail
Validation of leadless atrioventricular synchronous pacing with Holter-ECG: a pilot study
Doctor S. Briongos Figuero (Madrid, ES)
Abstract Slides

Access the full session

Session thumbnail
Device therapy e-posters

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021
You may be interested in
thumbnail
Congress Presentation
Implantable cardioverter-defibrillator
thumbnail
Congress Presentation
When to consider device therapy in HFrEF - discussion
thumbnail
Congress Session
Debate on primary prevention in ICD therapy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources